Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Male and female mice have different skin thickness, and hormones affect their skin and hair growth differently.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.

As women age, they experience changes in hair density and volume, face challenges in distinguishing normal hair loss from disease, and have limited access to treatments for hair issues.

No significant link was found between the studied genes and female hair loss in the Polish population.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Spironolactone may effectively treat female hair loss, especially with hyperandrogenism signs.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Women with excessive body hair often have higher male hormones and related health issues.

FAI is a better marker for predicting female hair loss than testosterone or SHBG alone.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Women with more body hair tend to have thicker belly fat and more metabolic health issues.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Androgen receptors significantly affect hair loss in women with androgenetic alopecia.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.